DEVELOPMENT OF THERAPEUTIC AGENTS: THE MATERNAL - FETAL PERSPECTIVE

C. Gedeon; F. Garcia Bournissen; G. Koren

doi:10.1002/9780470571224.pse464

DEVELOPMENT OF THERAPEUTIC AGENTS: THE MATERNAL - FETAL PERSPECTIVE

C. Gedeon
, F. Garcia Bournissen
, G. Koren

פרסום מחקרי: פרק בספר / בדוח / בכנס › פרק › ביקורת עמיתים

תקציר

Our objective in this chapter will be to present the state of relevant research and to stimulate interest in research efforts aimed at developing selective drugs for use in pregnancy. The hope is to explore therapeutic strategies that can either reduce unnecessary fetal exposure to drugs required by the mother or, in some instances, reduce maternal exposure to drugs destined for fetal treatment.

שפה מקורית	אנגלית
כותר פרסום המארח	Pharmaceutical Sciences Encyclopedia
עמודים	1-18
מספר עמודים	18
מסת"ב (אלקטרוני)	9780470571224
מזהי עצם דיגיטלי (DOIs)	https://doi.org/10.1002/9780470571224.pse464
סטטוס פרסום	פורסם - 1 ינו׳ 2010
פורסם באופן חיצוני	כן

גישה למסמך

10.1002/9780470571224.pse464

קבצים וקישורים אחרים

Link to publication in Scopus

פורמט ציטוט ביבליוגרפי

@inbook{c272e4b700b640c3aae4c23ae89d5a52,

title = "DEVELOPMENT OF THERAPEUTIC AGENTS: THE MATERNAL - FETAL PERSPECTIVE",

abstract = "Our objective in this chapter will be to present the state of relevant research and to stimulate interest in research efforts aimed at developing selective drugs for use in pregnancy. The hope is to explore therapeutic strategies that can either reduce unnecessary fetal exposure to drugs required by the mother or, in some instances, reduce maternal exposure to drugs destined for fetal treatment.",

keywords = "Orphan Drug Act, atosiban, diclectin, glyburide (glibenclamide), pregnancy",

author = "C. Gedeon and Bournissen, \{F. Garcia\} and G. Koren",

note = "Publisher Copyright: {\textcopyright} 2010 John Wiley \& Sons, Inc.",

year = "2010",

month = jan,

day = "1",

doi = "10.1002/9780470571224.pse464",

language = "אנגלית",

pages = "1--18",

booktitle = "Pharmaceutical Sciences Encyclopedia",

}

TY - CHAP

T1 - DEVELOPMENT OF THERAPEUTIC AGENTS

T2 - THE MATERNAL - FETAL PERSPECTIVE

AU - Gedeon, C.

AU - Bournissen, F. Garcia

AU - Koren, G.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Our objective in this chapter will be to present the state of relevant research and to stimulate interest in research efforts aimed at developing selective drugs for use in pregnancy. The hope is to explore therapeutic strategies that can either reduce unnecessary fetal exposure to drugs required by the mother or, in some instances, reduce maternal exposure to drugs destined for fetal treatment.

AB - Our objective in this chapter will be to present the state of relevant research and to stimulate interest in research efforts aimed at developing selective drugs for use in pregnancy. The hope is to explore therapeutic strategies that can either reduce unnecessary fetal exposure to drugs required by the mother or, in some instances, reduce maternal exposure to drugs destined for fetal treatment.

KW - Orphan Drug Act

KW - atosiban

KW - diclectin

KW - glyburide (glibenclamide)

KW - pregnancy

UR - https://www.scopus.com/pages/publications/105031318345

U2 - 10.1002/9780470571224.pse464

DO - 10.1002/9780470571224.pse464

M3 - ???researchoutput.researchoutputtypes.contributiontobookanthology.chapter???

AN - SCOPUS:105031318345

SP - 1

EP - 18

BT - Pharmaceutical Sciences Encyclopedia

ER -

DEVELOPMENT OF THERAPEUTIC AGENTS: THE MATERNAL - FETAL PERSPECTIVE

תקציר

גישה למסמך

קבצים וקישורים אחרים

טביעת אצבע

פורמט ציטוט ביבליוגרפי